The incremental increase is routine for a passive manager. Monitor the next 13F filing for any change in Davis Selected Advisers' position size relative to this disclosure.
VTRS drugs
VTRS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $19.91entry
- T+1 · 8d ago +2.91%α +0.55% · $20.49
- T+5 · 4d ago +4.57%α +1.98% · $20.82
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Davis Selected Advisers filed an amended Schedule 13G disclosing a 6.3% passive stake in Viatris as of September 30, 2026, up from 6.1% in the prior filing. The increase is routine for a passive investment manager and does not signal a change in investment thesis.
Key Financial Metrics
Key Facts
- Davis Selected Advisers reported beneficial ownership of 72,403,329 shares of Viatris common stock as of September 30, 2026.
- The stake represents 6.3% of shares outstanding, up from 6.1% in the prior filing (70,080,338 shares as of August 12, 2026).
- The filing is a passive investment disclosure under Rule 13d-1(b).
- The increase of approximately 2,323,000 shares is consistent with routine portfolio adjustments by a passive manager.
Financial Impact
Increase of approximately 2.3 million shares, stake value roughly $350M based on market cap of $22.1B and 6.3% stake.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001036325-26-000035 |
| Document: 0001036325-26-000035-index.html | 0001036325-26-000035 |
| Document: 0001036325-26-000035.txt | 0001036325-26-000035 |
Track record
22 reports on VTRS
3 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +16.85% at T+60 after the Aug 6, 2026 report. 7 of 9 went positive at some point.
Filters
- Nov 17, 2026today 8-K Neutral 4/10 Entry $20.51 Now $20.49 −0.10% settles Feb 16
- Nov 17, 2026today Press Release Neutral 4/10 Entry $20.89 Now $20.49 −1.91% settles Feb 16
- Nov 16, 20261d ago SC 13G/A Neutral 2/10 Entry $20.84 Now $20.49 −1.68% settles Feb 12
- Nov 6, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $19.91 Now $20.49 +2.91% settles Feb 4
- Nov 5, 202612d ago 8-K Mixed 6/10 Entry $18.97 Now $20.49 +8.01% settles Feb 3
- Nov 4, 202613d ago Press Release Neutral 2/10 Entry $19.22 Now $20.49 +6.61% settles Feb 2
- Oct 30, 202618d ago Press Release Bullish 6/10 Entry $19.04 Now $20.49 +7.64% settles Jan 28
- Oct 29, 202619d ago Institutional Cluster Bullish 4/10 Entry $19.20 Now $20.49 +6.72% settles Jan 27
- Oct 16, 20264w ago Press Release Bullish 6/10 Entry $18.26 Now $20.49 +12.21% settles Jan 14
- Oct 8, 20265w ago 8-K Bullish 7/10 Entry $17.44 Now $20.49 +17.49% settles Jan 5
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers